The Greater Good
Pause the trainer at 1:48 and see my sweet husband with my beloved Chandler on his shoulders and holding my darling Webster's hand, as they walk with Ashley Brock's parents in the Green our Vaccines rally in 2008.
News and commentary on the autism epidemic and my beautiful boy who is living with autism.
Child Flu Vaccine Seizures?
Posted by Sharyl Attkisson
More confusing news for parents trying to do the best, safest things for their children when it comes to vaccination.
According to a Vaccine Safety "update" issued by the FDA on Jan. 20, there's been an increase in reports of febrile seizures among infants and children following this year's flu vaccine. Febrile seizures are seizures associated with fever.
According to the FDA:
"FDA and CDC have recently detected an increase in the number of reports to VAERS of febrile seizures following vaccination with Fluzone (trivalent inactivated influenza vaccine or TIV, manufactured by Sanofi Pasteur, Inc.). Fluzone is the only influenza vaccine recommended for use for the 2010-2011 flu season in infants and children 6-23 months of age. These reported febrile seizures have primarily been seen in children younger than 2 years of age."
Bloomberg Businessweek:
Nearly Half of Americans Still Suspect Vaccine-Autism Link
18% don't trust measles-mumps-rubella shot, and 30% are undecided, Harris Interactive/HealthDay poll finds
By Amanda Gardner
Just a slim majority of Americans -- 52 percent -- think vaccines don't cause autism, a new Harris Interactive/HealthDay poll found.
Conversely, 18 percent are convinced that vaccines, like the measles-mumps-rubella (MMR) vaccine, can cause the disorder, and another 30 percent aren't sure.
The poll was conducted last week, following news reports that said the lead researcher of a controversial 1998 study linking autism to the MMR vaccine had used fraudulent research to come to his conclusion.
The poll also found that parents who have lingering doubts about the vaccine were less likely to say that their children were fully vaccinated (86 percent), compared to 98 percent of parents who believe in the safety of vaccines.
Still, the percentage of fully vaccinated children remains high, at 92 percent, the poll found.
"This sounds like a cup half-empty/cup half-full story," said Humphrey Taylor, chairman of The Harris Poll. He noted that while the number of people who believe in a connection between vaccines and autism is "only 18 percent," that nonetheless translates to "millions and millions and millions of people, and it's clear that in some cases that has led them to not vaccinate their children."
Vaccine safety has been a major concern for many parents since the publication of the 1998 study, led by now disgraced British doctor Andrew Wakefield, which concluded that the MMR vaccine caused autism. The journal that originally published the study, The Lancet, has since retracted the paper and Wakefield was recently barred from practicing medicine in Britain.
In recent weeks, another leading British medical journal, BMJ, has published a series of articles purporting to expose deliberate fraud by Wakefield in his handling of the research that served as the basis for the 1998 study.
In the new Harris Interactive/HealthDay poll, 69 percent of respondents said they had heard about the theory that some vaccinations can cause autism.
But only half (47 percent) knew that the original Lancet study by Wakefield and other researchers had been retracted, and that some of that research is now alleged to be fraudulent.
"Forty-seven percent is a huge number and this is a relatively new thing [allegations of fraud], so it's remarkable that they have heard of it. But that still means that half the population has not," Taylor said.
Still, the retraction and allegations of fraud do seem to have influenced public perception. Among those who had been following the news about Wakefield, only 35 percent believed the vaccine-autism theory, compared to 65 percent who had not kept up to date on the latest developments.
"There seems to be reasonable support for vaccination and I think this will increase with the revelation that a lot of this stuff was based on fraud or bad science," said Dr. Kenneth Bromberg, chairman of pediatrics and director of the Vaccine Research Center at the Brooklyn Hospital Center in New York City.
Overall, 69 percent of adults polled agreed that schools should require vaccinations -- including, interestingly, 52 percent of those who believe that autism might be connected to vaccinations.
Sixteen percent of all adults surveyed said they knew of at least one family whose children had not received all recommended vaccines due to concerns about autism. One-quarter of those who believed the vaccine-autism theory said they knew at least one family that had not fully vaccinated their children.
Barbara Loe Fisher, co-founder and president of the National Vaccine Information Center, which supports more research into the safety of vaccinations, said autism is just one concern linked to vaccines.
"Parents have legitimate questions about vaccine risks and want better vaccine science to define those risks for their own child," she said. "This concern long predated the debate about vaccines and autism. The National Childhood Vaccine Injury Act of 1986 was passed by Congress, in part, to address those concerns but has not done the job.
"The Harris poll points out the urgent need for a renewed effort to conduct new vaccine safety studies that are methodologically sound and free from real or perceived conflicts of interest," Fisher added, "or a significant portion of the public will continue to question the conclusions."
According to the U.S. Centers for Disease Control and Prevention, an estimated one in 110 children in the United States has an autism spectrum disorder, part of a group of developmental disabilities that can cause significant social, communication and behavioral challenges.
The Harris Interactive/HealthDay poll was conducted online within the United States from Jan. 11-13, and included 2,026 adults over the age of 18. Figures for age, sex, race/ethnicity, education, region and household income were weighted where necessary to bring them into line with their actual proportions in the population.
More information
Read more about the poll methodology and findings at Harris Interactive.
Novartis Q4 profit down as vaccine demand drops
Jan 27, 2011 5:32 AM ET
By The Associated Press
GENEVA (AP) — Swiss drug maker Novartis AG saw fourth quarter net profit slip 2 percent on the year to $2.32 billion amid one-off charges and a sharp drop in demand for its pandemic flu vaccine, the company said Thursday.
Profit in the October-December period was hurt by one-time charges of $789 million, including restructuring costs in the U.S. and Germany — only partially offset by a one-time gain of $392 million, the pharmaceutical company said.
Revenue in the fourth quarter grew from $12.92 billion to $14.19 billion. However, the vaccine division suffered a 74 percent decline in sales to $361 million following the end of the pandemic flu in 2010, after sales for the flu vaccine totaled $1 billion a year earlier.
The maker of hypertension drug Diovan and anticancer treatment Glivec — known as Gleevec in the United States — said its 2010 full year sales were up by 14 percent to $50.62 billion, including $2.4 billion revenue from the full consolidation of eye care specialist Alcon, Inc.
Full year 2010 net profit was up to $8.45 billion from $9.96 billion a year earlier, the company, based in Basel, said.
"Novartis achieved excellent results in 2010 as all divisions contributed to above-market growth," Chief Executive Joseph Jimenez said.
The company's results were helped by 13 key product approvals and the breakthrough of the multiple sclerosis medication, Gilenya, which has also been launched in the U.S., he said.
Analysts at Zuercher Kantonalbank said while Novartis' revenue is fully in line with market expectations, its net profit remained slightly below expectations.
In its outlook, Novartis said it expects sales to grow at constant currency rates by a "double-digit mark," and productivity gains to help improve margins while absorbing price cuts, generic competition and the loss of the pandemic flu vaccine sales.
The company's shares were trading lower on Switzerland's stock exchange Thursday morning, falling by 1.74 percent to 53.50 Swiss Francs ($56.71).
Thomas H. Glocer
Chief executive officer, Thomson Reuters Corporation (information and services company for businesses and professionals). Director, Thomson Reuters Corporation, Partnership for New York City. New Merck director since November 3, 2009
British ban for doctor at heart of MMR vaccine row
By Kate Kelland, Health and Science Correspondent
LONDON | Mon May 24, 2010 12:44pm BST
LONDON (Reuters) - A doctor whose claims of links between vaccination and autism triggered a scientific storm before being widely discredited was struck off the medical register Monday for professional misconduct.
Dr Andrew Wakefield's 1998 study led many parents to refuse to have their children vaccinated with the measles, mumps and rubella (MMR) shot and has been blamed for a big rise in measles cases in the United States and parts of Europe in recent years.
A disciplinary panel of the General Medical Council (GMC) found that Wakefield had acted in a "dishonest," "misleading" and "irresponsible" way during his research.
The ruling means Wakefield, who now lives and works in the United States, can no longer practise as a doctor in Britain, but can continue to work in medicine outside the UK.
His paper, published in The Lancet medical journal but since widely discredited, caused one of the biggest medical rows in a generation.
"The panel has determined that Dr Wakefield's name should be erased from the medical register," the GMC said in a statement.
Wakefield had failed to disclose various details about the funding of the study -- a failure the GMC described as "dishonest and misleading" -- and had acted "contrary to the clinical interests" of the children involved in his research.
Striking Wakefield off the medical register was "the only sanction that is appropriate to protect patients" and was in the wider public interest. It was also "proportionate to the serious and wide-ranging findings made against him," the statement said.
Data released last February for England and Wales showed a rise in measles cases of more than 70 percent in 2008 from the previous year, mostly due to a fall in the number of children being vaccinated. Vaccination rates are now recovering.
Terence Stephenson, president of the Royal College of Paediatrics and Child Health, said the false suggestion of a link between autism and the MMR vaccine had caused "untold damage" to vaccination programs.
"We cannot stress too strongly that all children and young people should have the MMR vaccine. Overwhelming scientific evidence shows that it is safe," he said in a statement.
Wakefield defended his work, and said the GMC had sought to deny that the case against him was related to whether the vaccine was safe, and specifically, whether it caused autism.
"Efforts to discredit and silence me through the GMC process have provided a screen to shield the government from exposure on the ... MMR vaccine scandal," he said in a statement.
The GMC said his refusal to accept that he had made mistakes meant that a temporary suspension of Wakefield's licence was not enough and he should be banned altogether.
"Dr Wakefield's continued lack of insight as to his misconduct serve only to satisfy the panel that suspension is not sufficient and that his actions are incompatible with his continued registration as a medical practitioner," it said.
(Editing by Andrew Roche)
Interviewer: "Why does this report from your own agency list neurological complications as a possibility?"
Director of CDC: "I think the consensus of the scientific community was that the evidence relating neurologic disorders to immunizations was such that they did not feel that this association was a real one."
For example, what is the purpose of putting up a billboard that is telling me a child is born with autism every 20 minutes? What can I possibly do other than sit in my car and mutter to myself, “Well that sucks.” Maybe if there was a cure or even ways to help prevent autism, it might make more sense to have a billboard. Then it would reinforce concepts in people’s head that they could apply later like “only you could prevent forest fires” or “don’t eat cheese before noon.” But frankly, all this billboard is really saying is, “Beware, autistic people are everywhere,” and I’m sure that isn’t the message they want to get across. We already know autism exists; give us something we can work with. If the autism front wants to put us through a year of sappy ads and TV specials, than at least make it worth the time and money and headache. Teach us something. I was on my way to New York City this weekend and every toll booth was littered with autism propaganda. Did I learn anything? No. There are more intelligent ways to get out a message to the public.
“There have been at least 15 very good scientific studies and the Institute of Medicine that has searched this out. And they have concluded that there really is no association between vaccines and autism”
“33,000 children a year are saved from death associated with vaccines because of our immunization program”
“One of the things that concerns me, while the attention is focused on vaccines, in a sense, it means that people are not looking for other causes."
“And we have got to keep reminding ourselves that the vaccine story is one that has been debated for many, many years now. We keep looking and looking and looking and really cannot turn up any information”.
David Kirby: HBO and Autism: Perfect Together
Today, March 25, 2008,
Huffington Post
David Kirby
A lot of adults (myself among them) are arguing very vocally right now over the scope, cause, and impact of autism in America. Acrid debates over mercury, vaccines, special diets, alternative therapies and conceded court cases are flooding the media almost daily.
It's enough to give autism a bad name.
Then, along comes an honest little documentary like "Autism: The Musical." This all-too-real movie lifts the heart up and then slams it right back down on the pavement--and we love every minute of it.
This simply shot, beautifully conveyed portrait of life with autism premieres tonight on HBO (and will stream for free for one week at hbo.com). It serves to remind us all that, no matter what "causes autism," no matter what, if anything might "cure" it, children affected by the disorder deserve all of the honor, love and patience that we, a nation consumed by our own attention deficits, can muster.
This moving and funny film opens with the jarring data that autism in America has spiked from 1-in-10,000 kids in 1980 to 1-in-150 today.
But instead of dwelling on the cause of autism, the film focuses mostly on five wonderful kids - two boys with very high functioning autism who are brilliant, charming, and yes, "quirky;" a teenage girl who sings (and looks) like an angel; a little boy who rarely speaks, but who can express himself vividly through his cello; and one Russian adopted boy who is completely nonverbal (until he gets a computer) and who will break your heart when you see him.
Anyway, they put on a show, and it is riveting, joyous and tearful. But the real message here is that kids with autism are human beings, just like everyone else on God's green earth - with their own hopes and fears, intellects and personalities.
They deserve more than our compassion, our love and our dollars. They deserve our respect.
Meanwhile, "Autism: The Musical" unflinchingly shows just how stressful the disorder can be on families. The weight on couples is obvious: One marriage suffers through infidelity, another ends in painful divorce.
Some people might complain that the potential causes and treatments of autism are only touched upon here - though we do see clear evidence of heart-wrenching autistic "regression," and there is some talk about vaccines, environmental toxins and "damaged kids."
Others might worry that the portraits of the two high functioning boys - so bright and charismatic you want to hang out with them for hours (though their peers shun them into a lonely world of their own) - will leave the mistaken impression that most children with autism are like this. If they were, then the epidemic might be slightly less painful to bear.
Sadly, however, most kids with autism are more than just a little "quirky." And as much as we truly adore all the children in this film, few, if any parents of "typical" kids could honestly say, "I wish my child were like that."
"Autism: The Movie," then, gives us the whole unvarnished "spectrum" of autism spectrum disorder. Little Neal, the adopted boy who can neither speak nor hold a gaze, tells us what we should know: These extraordinary children (and many adults with autism, too) need and deserve our attention, and help.
Here, I hope, is a movie that everyone can watch and appreciate. From those of us who think that many autism cases were triggered by environmental toxins; to the "neuro-diversity" people, some of whom think that autism is a natural, inborn variation of human brain wiring, and should be celebrated, not treated; to the CDC, who wishes we would ALL just go away.
Please watch this film: You will be treated to an achingly accurate portrait of what autism is, isn't, and can be.
"Do you believe that all vaccines should be used on every child?"
"Yes. I think any of the vaccines we have today have been tested and proven to be safe, and the credible studies don't show any relationship between vaccines and permanent injury. So we favor this and we know that unless we have vaccination rates that are in the 90 to 95% range we are not going to prevent epidemics from coming into this country of measles, of polio, from countries where these diseases are still endemic. So its very important that we vaccinate all our children."
"The Vaccine Injury Table (Table) makes it easier for some people to get compensation. The Table lists and explains injuries/conditions that are presumed to be caused by vaccines. It also lists time periods in which the first symptom of these injuries/conditions must occur after receiving the vaccine. If the first symptom of these injuries/conditions occurs within the listed time periods, it is presumed that the vaccine was the cause of the injury or condition unless another cause is found. For example, if you received the tetanus vaccines and had a severe allergic reaction (anaphylaxis) within 4 hours after receiving the vaccine, then it is presumed that the tetanus vaccine caused the injury if no other cause is found."
"Multiple Sclerosis: Although no causal relationship has been established, rare instances of exacerbation of multiple sclerosis have been reported following administration of hepatitis B vaccines and other vaccines. In persons with multiple sclerosis, the benefit of immunization for prevention of hepatitis B infection and sequelae must be weighed against the risk of exacerbation of the disease."
"Carcinogenesis, Mutagenesis, Impairment of Fertility: ENGERIX-B has not been evaluated for carcinogenic or mutagenic potential, or for impairment of fertility."
"Postmarketing Reports: Additional adverse experiences have been reported with the commercial use of ENGERIX-B. Those listed below are to serve as alerting information to physicians.
Hypersensitivity: Anaphylaxis; erythema multiforme including Stevens-Johnson syndrome; angioedema; arthritis. An apparent hypersensitivity syndrome (serum sickness–like) of delayed onset has been reported days to weeks after vaccination, including: arthralgia/arthritis (usually transient), fever, and dermatologic reactions such as urticaria, erythema multiforme, ecchymoses, and erythema nodosum (see CONTRAINDICATIONS).
Cardiovascular System: Tachycardia/palpitations.
Respiratory System: Bronchospasm including asthma-like symptoms.
Gastrointestinal System: Abnormal liver function tests; dyspepsia.
Nervous System: Migraine; syncope; paresis; neuropathy including hypoesthesia, paresthesia, Guillain-Barré syndrome and Bell’s palsy, transverse myelitis; optic neuritis; multiple sclerosis; seizures.
Hematologic: Thrombocytopenia.
Skin and Appendages: Eczema; purpura; herpes zoster; erythema nodosum; alopecia.
Special Senses: Conjunctivitis; keratitis; visual disturbances; vertigo; tinnitus; earache."
"CONTRAINDICATIONS - Hypersensitivity to any component of the vaccine, including yeast, is a contraindication. This vaccine is contraindicated in patients with previous hypersensitivity to any hepatitis B-containing vaccine."
"Controlled studies on FLUVIRIN® have not been conducted to demonstrate safety in pregnant women."
"CONTRAINDICATIONS
INFLUENZA VIRUS IS PROPAGATED IN EGGS FOR THE PREPARATION OF INFLUENZA VIRUS VACCINE. THUS, THIS VACCINE SHOULD NOT BE ADMINISTERED TO ANYONE WITH A HISTORY OF HYPERSENSITIVITY (ALLERGY) TO CHICKEN EGGS, CHICKEN, CHICKEN FEATHERS OR CHICKEN DANDER.
THE VACCINE IS ALSO CONTRAINDICATED IN INDIVIDUALS HYPERSENSITIVE TO ANY COMPONENT OF THE VACCINE INCLUDING THIMEROSAL (A MERCURY DERIVATIVE) (SEE ADVERSE REACTIONS). EPINEPHRINE INJECTION (1:1000) MUST BE IMMEDIATELY AVAILABLE SHOULD AN ACUTE ANAPHYLACTIC REACTION OCCUR DUE TO ANY COMPONENT OF THE VACCINE.
IMMUNIZATION SHOULD BE DELAYED IN PERSONS WITH AN ACTIVE NEUROLOGICAL DISORDER
CHARACTERIZED BY CHANGING NEUROLOGICAL FINDINGS, BUT SHOULD BE CONSIDERED WHEN THE
DISEASE PROCESS HAS BEEN STABILIZED.
THE OCCURRENCE OF ANY NEUROLOGICAL SYMPTOMS OR SIGNS FOLLOWING ADMINISTRATION OF ANY
VACCINE IS A CONTRAINDICATION TO FURTHER USE.
THE VACCINE SHOULD NOT BE ADMINISTERED TO PERSONS WITH ACUTE FEBRILE ILLNESSES UNTIL THEIR TEMPORARY SYMPTOMS AND/OR SIGNS HAVE ABATED."
WARNINGS
Influenza Virus Vaccine should not be given to individuals with thrombocytopenia or any coagulation disorder that would contraindicate intramuscular injection unless, in the judgment of the physician, the potential benefits clearly outweigh the risk of administration.
Patients with impaired immune responsiveness, whether due to the use of immunosuppressive therapy (including irradiation, corticosteroids, antimetabolites, alkylating agents, and cytotoxic agents), a genetic defect, human immunodeficiency virus (HIV) infection, or other causes, may have a reduced antibody response in active immunization procedures.
"CONTRAINDICATIONS
None."
"WARNINGS
None."
"No studies regarding the simultaneous administration of inactivated influenza vaccine and other childhood vaccines have been conducted."
"CONTRAINDICATIONS
Hypersensitivity to any component of the vaccine, including gelatin.
Do not give M-M-R II to pregnant females; the possible effects of the vaccine on fetal development are unknown at this time. If vaccination of postpubertal females is undertaken, pregnancy should be avoided for three months following vaccination (see INDICATIONS AND USAGE, Non-Pregnant Adolescent and Adult Females and PRECAUTIONS, Pregnancy).
Anaphylactic or anaphylactoid reactions to neomycin (each dose of reconstituted vaccine contains approximately 25 mcg of neomycin).
Febrile respiratory illness or other active febrile infection. However, the ACIP has recommended that all vaccines can be administered to persons with minor illnesses such as diarrhea, mild upper respiratory infection with or without low-grade fever, or other low-grade febrile illness.
Patients receiving immunosuppressive therapy. This contraindication does not apply to patients who are receiving corticosteroids as replacement therapy, e.g., for Addison's disease.
Individuals with blood dyscrasias, leukemia, lymphomas of any type, or other alignant neoplasms affecting the bone marrow or lymphatic systems.
Primary and acquired immunodeficiency states, including patients who are immunosuppressed in association with AIDS or other clinical manifestations of infection with human immunodeficiency viruses;41-43 cellular immune deficiencies; and hypogammaglobulinemic and dysgammaglobulinemic states. Measles inclusion body encephalitis60 (MIBE), pneumonitis61 and death as a direct consequence of disseminated measles vaccine virus infection have been reported in immunocompromised individuals inadvertently vaccinated with measles-containing vaccine.
Individuals with a family history of congenital or hereditary immunodeficiency, until the immune competence of the potential vaccine recipient is emonstrated."
"WARNINGS
Due caution should be employed in administration of M-M-R II to persons with a history of cerebral injury, individual or family histories of convulsions, or any other condition in which stress due to fever should be avoided. The physician should be alert to the temperature elevation which may occur following vaccination (see ADVERSE REACTIONS).
Hypersensitivity to Eggs Live measles vaccine and live mumps vaccine are produced in chick embryo cell culture. Persons with a history of anaphylactic, anaphylactoid, or other immediate reactions (e.g., hives, swelling of the mouth and throat, difficulty breathing, hypotension, or shock) subsequent to egg ingestion may be at an enhanced risk of immediate-type hypersensitivity reactions after receiving vaccines containing traces of chick embryo antigen. The potential risk to benefit ratio should be carefully evaluated before considering vaccination in such cases. Such individuals may be vaccinated with extreme caution, having adequate treatment on hand should a reaction occur"
"The AAP states, "Persons who have experienced anaphylactic reactions to topically or systemically administered neomycin should not receive measles vaccine."
"So we favor this and we know that unless we have vaccination rates that are in the 90 to 95% range we are not going to prevent epidemics from coming into this country of measles, of polio, from countries where these diseases are still endemic. So its very important that we vaccinate all our children."
The Wrong Debate Over Autism
Why focusing on thimerosal misses a larger story
By Russ Juskalian Tue 11 Mar 2008 10:51 AM
Columbia Journalism Review
Back in 2005, CJR published a story by Daniel Schulman about media coverage of "whether a mercury-containing vaccine" preservative called thimerosal was to blame for an alarming spike in autism cases among a generation of children. Last summer, yet another study was released that showed no link between autism and vaccinations, and last week came news of a lawsuit settlement that required a girl's medical costs to be covered by the government after she was diagnosed with a rare mitchochondria disorder and autistic symptoms related to receiving nine vaccinations in one day. Clearly, the debate rages on, so we decided to take another look at the press-coverage landscape.
Schulman concluded in his piece that the media had been too quick to close the door on the potential link between thimerosal and autism. "[W]ith science left to be done and scientists eager to do it, it seems too soon for the press to shut the door on the debate," he wrote. He cited stories like a New York Times piece by Gardiner Harris and Anahad O'Connor in June of the same year, with the headline: "On Autism's Cause, It's Parents vs. Research".
Schulman, now an editor at Mother Jones, noted that while the vast majority of studies appeared to disprove a vaccine link to autism, there were serious researchers (notably Dr. Mady Hornig and Dr. Ezra Susser, both epidemiologists at Columbia's Mailman School of Public Health; Richard Deth, a Northeastern University pharmacologist; and Jill James, a professor of pediatrics at the University of Arkansas) who supported the possibility that environmental factors—and perhaps thimerosal in vaccinations—could at least be triggers for autism in predisposed populations that might otherwise not have developed the disorder.
(It's a lot like the global warming debate in reverse: almost every major study said there was no credence to the autism-vaccine link, but there were, and still are, a few credible voices out there saying the case isn't closed.)
So, where are we now?
Last summer, a report on vaccinations and neurological problems in children was published in the New England Journal of Medicine and the vaccine-autism debate got a little more fuel. Depending on which side of the fence you stand, the argument can be made that coverage of this report was good or bad. Autism is a touchstone issue, so it was often mentioned in headlines and stories, even if only to note that the study itself was not focused on autism.
A sample of stories and headlines from September 27, 2007, paints a picture:
Newsday: "CDC: Vaccines are safe; Though autism was not a focus, study says mercury preservative in shots did not cause neurological problems"
Federal health officials yesterday reassured parents that childhood vaccines are safe and that kids who got routine immunizations a decade ago when shots contained a controversial mercury preservative are not at risk of neurological problems….An investigation examining autism and thimerosal, the preservative that once was added to common vaccines, is expected to be published within 12 months, scientists at the Centers for Disease Control and Prevention said yesterday.
The New York Times: "Vaccine Compound Is Harmless, Study Says, as Autism Debate Rages"
Yet another study has found that a controversial vaccine preservative appears to be harmless. But the study is unlikely to end the increasingly charged debate about vaccine safety.
The Globe and Mail (Canada): "Vaccine preservative can cause tics; But according to U.S. research, thimerosal does not appear harmful to kids' learning skills or physical abilities"
"The scientific literature to date does not support a causal link between autism and thimerosal, but it's important to say this study isn't of autism," she said. "There's a separate CDC study ongoing that's going to get at that question to provide more information."
Even more recently, the issue of an autism-vaccine link came up in response to a settlement involving the government and nine-year-old Hannah Poling. Poling started showing symptoms typical of autism shortly after receiving a bundle of vaccinations when she was a toddler. The government decided that Poling's vaccinations, given on top of a rare metabolic disorder, caused her problems.
The headlines this time covered broader ground: KHBS Fort Smith, "Vaccine-Autism Link Unproven By Controversial Georgia Case"; Atlanta Journal-Constitution, "Ga. girl helps link autism to childhood vaccines"; The New York Times, "Deal in an Autism Case Fuels Debate on Vaccine".
Not even John McCain could let this one go by as was noted by Benedict Carey in the Times, in a piece titled, "Into the Fray Over the Cause of Autism":
"It's indisputable that autism is on the rise among children," Senator John McCain said while campaigning recently in Texas. "The question is, What's causing it? And we go back and forth, and there's strong evidence that indicates that it's got to do with a preservative in vaccines."
With that comment, Mr. McCain marked his entry into one of the most politicized scientific issues in a generation.
It appears that Schulman was on to something when he claimed the media had taken too narrow a tack on the autism-vaccine link issue. But he, too, may have had his keyboard aimed in the wrong place.
The problem with the coverage was not that the few credible opposition voices didn't receive balanced coverage, but rather that the whole issue of whether vaccines containing thimerosal or mercury cause autism served as a distraction from the ongoing efforts to tease apart the causes of this enigmatic disorder. That's not to say the vaccine issue shouldn't be covered at all, but that there are many more important—if less emotionally driven—questions related to autism that deserve further investigation.
Is autism caused by environmental factors? Can it be triggered by these factors? How does epidemiology try to solve these riddles? Are some people genetically predisposed to respond to environmental factors (like mercury)? Can we find a way to screen for these predispositions (like Poling's metabolic condition)? What else is in our environment that poses a risk?
Lest we forget about the long list of environmental contaminants that have been pointed out going back to Rachel Carson's Silent Spring, the AP just released its own investigation that found a wide array of pharmaceuticals in tap water across America. A potent reminder that while important, the vaccination story is only one part of a bigger issue.
Schulman is right about one thing: when we simplify science to "yes" or "no" questions the repercussions can be dangerous. And simply because a few scientist are in the minority does not mean their careers and their work should be dismissed with the wave of a hand.
We may never find an answer to the autism-vaccine debate that satisfies everyone—and that's okay. Science pushes on, and the myriad questions about autism will continue to be researched long after the last mercury-containing inoculation is administered.